Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič, Faculty of Medicine, University of Ljubljana, Slovenia.

Daša Zupančič is a distinguished academic and researcher specializing in cell biology, urothelial pathology, and medical education. Her extensive contributions to scientific research, particularly in the field of urothelial repair and cancer transformation, have earned her recognition, including the EMBO award. She has played a crucial role in mentoring and teaching, guiding future generations of researchers and medical professionals.

Profile

Orcid

✨ Early Academic Pursuits ✨

Daša Zupančič embarked on her academic journey with an unwavering passion for cell biology and medicine. She earned her Master’s degree in 2002 from the University of Ljubljana, Faculty of Medicine, where she meticulously explored cellular and molecular biological changes in the rat bladder urothelium following cyclophosphamide exposure. This formative research laid the foundation for her Ph.D., which she successfully completed in 2006, investigating the protective role of melatonin in urothelial injury and repair. Her dedication to advancing biomedical knowledge was evident from the very beginning of her scholarly career.

🎓 Professional Endeavors 🎓

Since 2006, Daša Zupančič has been an esteemed Associate Professor at the University of Ljubljana, Faculty of Medicine, Institute of Cell Biology. Prior to this, she gained valuable experience as a Young Researcher and Teaching Assistant from 1999 to 2006. Her extensive expertise and commitment to education have made her an integral part of the institution, where she continuously fosters scientific curiosity and excellence among students and colleagues alike.

🎡 Contributions and Research Focus 🎡

Throughout her career, Daša Zupančič has dedicated her research to understanding cellular mechanisms in urothelial biology and pathology. Her investigations into cyclophosphamide-induced urothelial injury, melatonin’s protective effects, and retinoid signaling pathways in urothelial cancer transformation have provided valuable insights into cellular repair processes. Her work extends beyond laboratory research, influencing the medical community’s approach to urothelial diseases and potential therapeutic advancements.

🏆 Accolades and Recognition 🏆

Her exceptional contributions to biomedical research have been recognized on multiple platforms. In 2017, she was honored with the prestigious EMBO award for her short-term scholarship project on the role of the retinoid signaling pathway in urothelial cancer transformation. This recognition underscores her significant impact on the scientific community and highlights her pioneering approach to understanding cancer pathophysiology.

👨‍🎓 Impact and Influence 👨‍🎓

A dedicated mentor, Daša Zupančič has guided numerous students towards academic excellence. Between 2014 and 2025, she has successfully mentored four master’s students and is currently supervising two more. In addition, she has overseen the research endeavors of four Ph.D. candidates, with one having successfully defended their dissertation in 2023 and another expected to graduate in 2025. Her mentorship has shaped the next generation of biomedical researchers, fostering a culture of rigorous inquiry and scientific discovery.

📚 Legacy and Future Contributions 📚

Beyond her research, Daša Zupančič plays a pivotal role in academia through her extensive teaching engagements. Since 2000, she has been a cornerstone of education at the University of Ljubljana, contributing to multiple faculties, including Medicine, Biotechnical Sciences, Health Sciences, and Pharmacy. She teaches a range of graduate and doctoral courses, covering essential subjects such as Medical Cell Biology, Immunology, and Research in Medicine. Her dedication to education ensures that her knowledge and expertise continue to shape the minds of aspiring medical professionals and researchers for years to come.

Publication

  • Vitamin A‐Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide‐Induced Injury in Mice
    Authors: Brina Dragar, Simona Kranjc Brezar, Maja Čemažar, Tanja Jesenko, Rok Romih, Mateja Erdani Kreft, Tadeja Kuret, Daša Zupančič
    Year: 2025

 

  • Selective Targeting of Lectins and Their Macropinocytosis in Urothelial Tumours: Translation from in vitro to ex vivo
    Authors: Nataša Resnik, Tanja Višnjar, Tomaž Smrkolj, Mateja Erdani Kreft, Rok Romih, Daša Zupančič
    Year: 2023

 

  • Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis
    Authors: Daša Zupančič, Peter Veranič
    Year: 2022

 

  • Transmission Electron Microscopy Demonstration of Reduced Endothelial Glycocalyx in Severe Preeclampsia
    Authors: Mugerli S, Zupančič D, Rok Romih, Lučovnik M
    Year: 2022

 

  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
    Authors: Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
    Year: 2021

 

  • Immunohistochemistry as a Paramount Tool in Research of Normal Urothelium, Bladder Cancer and Bladder Pain Syndrome
    Authors: Daša Zupančič, Rok Romih
    Year: 2021

 

  • Combined Lectin- and Immuno-Histochemistry (CLIH) for Applications in Cell Biology and Cancer Diagnosis: Analysis of Human Urothelial Carcinomas
    Authors: Daša Zupančič
    Year: 2020

 

  • Vitamin A Rich Diet Diminishes Early Urothelial Carcinogenesis by Altering Retinoic Acid Signaling
    Authors: Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
    Year: 2020

 

  • Lectins as Possible Tools for Improved Urinary Bladder Cancer Management
    Authors: Daša Zupančič
    Year: 2019

 

  • Co-Culturing Porcine Normal Urothelial Cells, Urinary Bladder Fibroblasts and Smooth Muscle Cells for Tissue Engineering Research
    Authors: Daša Zupančič
    Year: 2018

 

🌟 Conclusion 🌟

With a career dedicated to pioneering research, impactful mentorship, and transformative education, Daša Zupančič continues to leave a lasting legacy in the scientific and academic communities. Her work not only enhances understanding of urothelial biology but also inspires innovation and discovery among young scientists. As she continues her academic and research endeavors, her influence on the field will undoubtedly grow, shaping the future of biomedical sciences.

 

EMRE MISIR | Cognitive Neuroscience | Young Scientist Award

Published on by Neuroscientists

Assist. Prof. Dr. EMRE MISIR | Cognitive Neuroscience | Young Scientist Award

Assist. Prof. Dr.  EMRE MISIR, Baskent University, Turkey.

Dr. Emre MISIR is a distinguished psychiatrist and neuroscience researcher, whose academic journey began at Adnan Menderes University and led to specialization in psychiatry at Dokuz Eylül University. His professional career includes serving as a Specialist Physician at Yozgat City Hospital before transitioning to an academic role at Başkent University Faculty of Medicine. Currently, he is pursuing a Ph.D. in Interdisciplinary Neuroscience at Ankara University, focusing on Theory of Mind in Obsessive-Compulsive Disorder (OCD). His outstanding exam scores, professional memberships, and active research contributions underscore his dedication to advancing psychiatry.

Profile

Orcid

Early Academic Pursuits 🎓

Born on July 16, 1989, in Şahinbey, Gaziantep, Turkey, Dr. Emre MISIR embarked on an academic journey rooted in a passion for medicine and mental health. He completed his medical education at Adnan Menderes University between 2006 and 2012, where his keen interest in the complexities of the human mind began to take shape. His dedication and academic excellence led him to pursue a specialization in psychiatry at Dokuz Eylül University Faculty of Medicine, where he trained extensively from 2012 to 2017.

Professional Endeavors 🏥

Following his specialization, Dr. MISIR served as a Specialist Physician at Yozgat City Hospital from 2017 to 2020, providing essential mental health care to diverse patient populations. In July 2020, he transitioned to Başkent University Faculty of Medicine, where he continued his professional practice before taking on a more academic role. By April 2020, his expertise and commitment to education earned him a Lecturer position at Başkent University, where he has been actively involved in mentoring young psychiatrists and medical students.

Contributions and Research Focus 🔬

With a profound interest in the intersection of psychiatry and neuroscience, Dr. MISIR has dedicated his research to understanding complex cognitive and psychological disorders. Currently pursuing a doctoral program in Interdisciplinary Neuroscience at Ankara University, his research explores the intricate mechanisms underlying obsessive-compulsive disorder (OCD). His thesis, titled “Theory of Mind in Patients with Obsessive-Compulsive Disorder: Relationship with Cognitive Functions, Overvalued Ideas, Insight, Schizotypal Personality Traits, and Other Clinical Characteristics,” under the supervision of Prof. Dr. Berna Binnur Kıvırcık Akdede, sheds light on the cognitive and neurobiological factors influencing psychiatric conditions.

Accolades and Recognition 🏅

Dr. MISIR’s commitment to academic excellence is reflected in his outstanding achievements in competitive examinations. His remarkable performance in the TUS Clinical Exam (Fall 2012) with a rank of 101, and his high ALES Numerical score of 88.58 demonstrate his academic rigor. Additionally, his proficiency in English, certified by a YÖKDİL score of 88.75, further amplifies his ability to contribute to international research and collaboration in psychiatry and neuroscience.

Impact and Influence 🌍

Beyond clinical practice and academia, Dr. MISIR is an active member of key professional organizations, including the Turkish Psychiatric Association, the Cognitive Behavioral Psychotherapy Association, and the Clinical Neuropsychopharmacology Association, where he serves as the Treasurer. His contributions to these organizations reflect his dedication to advancing psychiatric research and improving mental health treatments in Turkey and beyond. Through his engagement in professional networks, he has been instrumental in fostering interdisciplinary collaboration and promoting evidence-based psychiatric practices.

Legacy and Future Contributions 🚀

As a psychiatrist, researcher, and educator, Dr. MISIR continues to push the boundaries of neuroscience and psychiatric research. His work not only enhances the understanding of cognitive disorders but also paves the way for more effective diagnostic and therapeutic approaches. With his ongoing doctoral research and contributions to academic literature, he aspires to shape the future of psychiatric treatment, integrating neurobiological insights with clinical practice. His unwavering dedication to mental health and neuroscience ensures that his influence will extend beyond his current academic and clinical roles, leaving a lasting impact on the field.

Publication

  • Clinical Characteristics of Cognitive Subgroups of Obsessive Compulsive Disorder

    • Authors: Emre Mısır, Raşit Tükel, Berna Binnur Akdede, Emre Bora

    • Year: 2025

 

  • Validity and Reliability Study of the Turkish Form of the 4th Version of the Mental Illness: Clinicians’ Attitudes (MICA) Scale

    • Authors: Emre Mısır, Yasemin Hosgören Alıcı, Zeynep Bozkurt, Hüseyin Batuhan Elhan

    • Year: 2024

 

  • Functional connectivity in rumination: a systematic review of magnetic resonance imaging studies

    • Authors: Emre Mısır, Yasemin Hoşgören Alıcı, Orhan Murat Kocak

    • Year: 2023

 

  • Synaptic dysfunction in schizophrenia

    • Authors: Emre Mısır, Güvem Gümüş Akay

    • Year: 2023

 

  • The effects of catechol‐O‐methyltransferase single nucleotide polymorphisms on positive and negative symptoms of schizophrenia: A systematic review and meta‐analysis

    • Authors: Emre Misir, Mutlu Muhammed Ozbek, Eren Halac, Serkan Turan, Gokce Elif Alkas, Remzi Ogulcan Ciray, Cagatay Ermis

    • Year: 2022

 

  • DSM-5 Anksiyöz Distres Değerlendirme Ölçeği Türkçe Formunun Major Depresif Bozukluk için Geçerlilik ve Güvenilirlik Çalışması

    • Authors: Emre Mısır

    • Year: 2020

 

  • Reliability and validity of the Turkish Version of DSM-5 Anxious Distress Rating Scale for major depressive disorder

    • Authors: Misir, Emre; Hacimusalar, Yunus

    • Year: 2020

 

  • THE BRIEF RESIDENT WELLNESS PROFILE: VALIDITY AND RELIABILITY OF TURKISH VERSION

    • Authors: Misir, Gamze Akyol; Balik, Gurcan; Misir, Emre; Kartal, Mehtap

    • Year: 2020

 

  • The concept of schizotypy and schizotypal personality disorder

    • Authors: Misir, Emre; Alptekin, Koksal

    • Year: 2020

 

Conclusion 🌟

Dr. MISIR’s career embodies a commitment to merging clinical expertise with neuroscience research to enhance the understanding and treatment of psychiatric disorders. His contributions to academia, professional organizations, and clinical practice solidify his role as an influential figure in modern psychiatry. As he continues to explore the intricate mechanisms of mental health, his work promises to shape the future of psychiatric care and inspire the next generation of researchers and clinicians. His journey is one of excellence, innovation, and unwavering dedication to mental health and neuroscience.

İlyas UÇAR | Neuroimaging | Trailblazer in Neuroscience Award

Published on by Neuroscientists

Assoc.Prof.Dr. Ilyas UÇAR | Neuroimaging | Trailblazer in Neuroscience Award

Assoc. Prof. Dr. Ilyas UÇAR,  Erciyes University, Turkey.

İlyas Uçar is a dedicated academic and researcher specializing in anatomical sciences, particularly in developmental anatomy and teratology. His academic journey began with a Bachelor’s degree in Physiotherapy and Rehabilitation, followed by a Master’s and Ph.D. in Anatomy (Medicine) from Erciyes University. His research has focused on the effects of pharmaceutical agents such as Interferon and Paracetamol on embryonic and fetal development, shedding light on critical concerns regarding drug safety during pregnancy. As an Associate Professor, he has contributed to academia through teaching, mentorship, and interdisciplinary research, earning recognition for his impactful work. His studies have influenced medical guidelines and inspired  further research into prenatal health.

Profile

Google Scholar

Orcid

📚 Early Academic Pursuits

İlyas Uçar embarked on his academic journey with a deep-rooted interest in health sciences, particularly in the intricate mechanisms of human anatomy. He earned his Bachelor’s degree in Physiotherapy and Rehabilitation from Abant İzzet Baysal University in 2007, where he developed a strong foundation in musculoskeletal function and rehabilitation techniques. His passion for understanding the human body at a deeper level led him to pursue postgraduate studies, marking the beginning of an extensive academic exploration.

His pursuit of higher education continued at Erciyes University, where he completed his Master’s degree in Anatomy (Medicine) in 2014. Under the guidance of Doç. Dr. Tolga Ertekin, he conducted groundbreaking research on the effects of Interferon beta-1a (IFNβ-1A) and Interferon beta-1b (IFNβ-1B) on in vitro embryonic development. This study not only refined his expertise in developmental anatomy but also set the stage for his future contributions to teratology and embryological research.

🏥 Professional Endeavors

With a strong academic foundation, İlyas Uçar transitioned into professional academia, where he merged his passion for teaching with his commitment to scientific discovery. His doctoral studies at Erciyes University’s Institute of Health Sciences were a significant milestone, culminating in his Ph.D. in Anatomy (Medicine) in 2018. His dissertation, supervised by Prof. Dr. Erdoğan Unur, explored the potential teratogenic effects of paracetamol on fetal bone development, shedding light on critical concerns regarding prenatal medication exposure.

Following his doctoral achievements, he took on an active role in academia, mentoring students and engaging in interdisciplinary research. His teaching methods, rooted in both theoretical knowledge and practical application, have made a lasting impact on students specializing in anatomy and health sciences.

🔬 Contributions and Research Focus

İlyas Uçar’s research focuses on developmental anatomy, particularly the impact of pharmaceutical agents on embryonic and fetal growth. His studies on interferons and paracetamol have contributed valuable insights into the possible risks associated with commonly used medications during pregnancy. Through meticulous experimental methodologies, he has explored the implications of these substances on skeletal formation, paving the way for further advancements in medical safety guidelines.

In addition to his work in teratology, he has delved into the broader aspects of anatomical sciences, bridging the gap between clinical applications and fundamental research. His interdisciplinary approach has fostered collaborations with medical professionals, physiologists, and pharmacologists, further enriching the field of health sciences.

🏅 Accolades and Recognition

Throughout his career, İlyas Uçar has earned recognition for his dedication to research and education. His scholarly contributions have been acknowledged in scientific circles, with his research findings being cited in academic discussions on embryology and anatomy. His work has not only contributed to medical literature but has also influenced guidelines on drug safety during pregnancy.

As an esteemed faculty member, he has played a pivotal role in shaping the academic curriculum, ensuring that students receive a well-rounded education in anatomical sciences. His ability to inspire and guide young researchers has cemented his reputation as a mentor and leader in his field.

🌍 Impact and Influence

The influence of İlyas Uçar extends beyond the lecture halls and research laboratories. His findings have raised awareness about the importance of cautious pharmaceutical use during pregnancy, prompting further investigations into the long-term effects of medications on fetal development. His work continues to serve as a reference point for medical researchers, policymakers, and healthcare professionals seeking to enhance patient safety.His collaborations with medical institutions and research centers have facilitated knowledge exchange, ensuring that his discoveries have practical implications in clinical and pharmacological settings. By addressing critical questions in developmental anatomy, he has contributed to the broader understanding of how external factors influence human growth and development.

Publication

  • Effect of respiratory muscle training on pulmonary function and aerobic endurance in soccer players
    T. Ozmen, G.Y. Gunes, I. Ucar, H. Dogan, T.U. Gafuroglu – 2017

 

  • The effect of kinesio taping versus stretching techniques on muscle soreness, and flexibility during recovery from Nordic hamstring exercise
    T. Ozmen, G.Y. Gunes, H. Dogan, I. Ucar, M. Willems – 2017

 

  • The relationship between muscle size, obesity, body fat ratio, pain, and disability in individuals with and without nonspecific low back pain
    I. Ucar, C. Kararti, I. Cüce, E. Veziroğlu, A. Özüdoğru, F.A. Koçak, Y. Dadalı – 2021

 

  • Is scoliosis related to mastication muscle asymmetry and temporomandibular disorders? A cross-sectional study
    I. Ucar, S. Batin, M. Arik, A. Payas, E. Kurtoğlu, C. Kararti, T. Seber, et al. – 2022

 

  • Is the integration problem in the sensorimotor system the cause of adolescent idiopathic scoliosis?
    A. Payas, S. Batin, E. Kurtoğlu, M. Arik, T. Seber, I. Ucar, E. Unur – 2023

 

  • Analysis of changes in brain morphological structure of Taekwondo athletes by diffusion tensor imaging
    E. Kurtoğlu, A. Payas, S. Düz, M. Arik, I. Ucar, T.T. Tokmak, M.F. Erbay, N. Acer, et al. – 2023

 

  • The role of pineal gland volume in the development of scoliosis
    S. Batin, Y. Ekinci, K. Gürbüz, A. Payas, E. Kurtoğlu, I. Ucar, T. Seber, M. Arik, et al. – 2023

 

  • Masseter muscle thickness and elasticity in bruxism after exercise treatment: A comparison trial
    I. Ucar, C. Kararti, Y. Dadali, A. Özüdoğru, M. Okçu – 2022

 

  • The potential teratogenic effects of interferon beta-1a and interferon beta-1b on in vitro embryonic development
    I. Ucar, T. Ertekin, M. Nisari, D. Ceylan, Ö. Al, H. Ülger – 2016

 

  • Morphometric evaluation of acetabulum
    G.B. Uzun, M. Değermenci, I. Ucar, A. Arslan, M. Nisari – 2020

🔍 Conclusion

İlyas Uçar’s contributions to anatomical sciences extend beyond theoretical research, making a tangible impact on medical education and drug safety. His investigations into embryonic development have deepened the understanding of teratogenic risks, guiding both researchers and healthcare professionals. With a commitment to advancing knowledge through interdisciplinary collaboration, he continues to shape the future of anatomical and medical research. His legacy lies not only in his scientific discoveries but also in his role as an educator and mentor, ensuring that future generations carry forward his passion for medical science.

 

Elissavet Kollia | Developmental Neuroscience |Best Researcher Award

Published on by Neuroscientists

Ms. Elissavet Kollia | Developmental Neuroscience |Best Researcher Award 

Ms. Elissavet Kollia, National Kapodistrian University of Athens, Greece.

Ms. Elissavet Kollia is a distinguished pediatrician and researcher specializing in pediatric neurology. With an exceptional academic background, she graduated from the Medical School of the Democritus University of Thrace and pursued advanced postgraduate studies in Clinical Pediatrics and Nursing-Research. Her extensive clinical training, from pediatrics specialization to her current role at Konstantopouleio General Hospital “Agia Olga,” has solidified her expertise in child healthcare. Additionally, her research focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, contributing valuable insights to the field. Her dedication extends beyond clinical practice, as seen in her voluntary medical work and commitment to mentoring young professionals.

Profile

Google Scholar

🎓 Early Academic Pursuits

From an early age, Elissavet Kollia demonstrated exceptional academic abilities, graduating from the 4th General Lyceum of Agia Paraskevi with an outstanding general grade of “excellent 19.2.” Her passion for medicine led her to the Medical School of the Democritus University of Thrace, where she was admitted in September 2007. With dedication and perseverance, she successfully earned her medical degree in July 2013, achieving a commendable grade of “very good 8.33.” Shortly after, she obtained her license to practice as a doctor in Greece and later in Munich, Germany, reflecting her international medical competence.

🏥 Professional Endeavors

Ms. Kollia’s professional journey has been marked by extensive clinical training and hands-on experience in pediatrics. She began her specialization at the Pediatric Clinic of the General Hospital of Karpenisi from June 2014 to October 2016. Her commitment to healthcare extended beyond hospitals as she served as a rural doctor at the Primary Health Care Center of Agios Nikolaos, Evrytania, actively participating in emergency care at the General Hospital of Karpenisi. Her expertise deepened when she became a scientific associate at the Pediatric Neurology Unit of the First Pediatric Clinic of the National University of Athens. She then pursued her residency in pediatrics at the First University Pediatric Clinic – Children’s Hospital “Agia Sophia” from November 2018 to May 2022, ultimately obtaining her specialty title in June 2022. Currently, she is serving as a pediatrician at the Konstantopouleio General Hospital “Agia Olga,” continuing her mission to provide excellent pediatric care.

📝 Contributions and Research Focus

Ms. Kollia’s dedication to medical research has significantly contributed to the field of pediatric neurology. Her postgraduate studies in “Clinical Pediatrics and Nursing-Research,” completed with an exceptional grade of “Excellent 9.31,” strengthened her academic foundation. Her ongoing doctoral dissertation at the National Kapodistrian University of Athens focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, a field crucial for advancing neurological care in children. Her research efforts have led to an upcoming publication in the European Journal of Paediatric Neurology, further establishing her as a valuable contributor to the scientific community.

🌟 Accolades and Recognition

Ms. Kollia’s unwavering commitment to medicine has been recognized through her outstanding academic achievements and professional milestones. From excelling in her graduate and postgraduate studies to securing prestigious residency and specialization opportunities, she has consistently demonstrated excellence in her field. Her acceptance into renowned institutions and her involvement in vital research projects underline her credibility and expertise in pediatric neurology.

💪 Impact and Influence

Beyond her clinical and academic contributions, Dr. Kollia has actively participated in voluntary medical programs, extending her expertise to underserved populations. She contributed to emergency case observations at the Children’s Hospital “Agia Sophia” and participated in medical landing programs in remote islands, showcasing her dedication to public health. Her influence extends to mentoring young medical professionals, sharing her knowledge, and contributing to the medical community’s growth.

💡 Legacy and Future Contributions

With a passion for advancing pediatric neurology, Dr. Kollia continues to shape the future of medical research and patient care. Her work in understanding movement disorders in children with epileptic encephalopathy holds the potential to improve diagnostic and therapeutic approaches in pediatric neurology. As she progresses in her career, her contributions to both clinical practice and scientific research will undoubtedly leave a lasting impact on the medical community and the lives of the children she treats.

 

Publication

  • Title: The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center
    Authors: V Zouvelou, D Yubero, L Apostolakopoulou, E Kokkinou, M Bilanakis, …
    Year: 2019

 

  • Title: MOTOR PHENOTYPING IN A GREEK COHORT OF PATIENTS WITH NEONATAL AND INFANTILE ONSET DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
    Authors: E Kollia, E Kokkinou, C Outsika, G Koltsida, V Zouvelou, A Vontzalidis, …
    Year: 2025

 

🌟 Conclusion

Ms. Kollia’s journey exemplifies the perfect blend of academic excellence, professional expertise, and compassionate patient care. Through her research and clinical endeavors, she continues to advance the understanding and treatment of pediatric neurological disorders. Her unwavering dedication to improving children’s health positions her as a leading figure in pediatric medicine. With her vision for excellence and continued contributions, she is set to leave a lasting impact on the medical field, inspiring future generations of healthcare professionals.

Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.

Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.

 

Profile

Scopus

 

🎓 Early Academic Pursuits

Pongrama Ramasoota’s journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.

🏥 Professional Endeavors

As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.

🦠 Contributions and Research Focus

Dr. Ramasoota’s contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.

🏆 Accolades and Recognition

Dr. Ramasoota’s contributions to science have been recognized with numerous prestigious awards. He was honored as Thailand’s Outstanding Researcher in 2020 and named Thailand’s Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventors’ Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.

🌍 Impact and Influence

With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasoota’s research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.

📚 Legacy and Future Contributions

Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.

Publication

  1. Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
    Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
    Year: 2024

 

  1. Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
    Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
    Year: 2024

 

  1. Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
    Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
    Year: 2024

 

  1. Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
    Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
    Year: 2023

 

  1. Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
    Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
    Year: 2023

 

  1. Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
    Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
    Year: 2022

 

  1. Title: Spread of a Novel Indian Ocean Lineage Carrying E1‐K211E/E2‐V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
    Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
    Year: 2022

 

🎯 Conclusion

Dr. Ramasoota’s work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.

 

Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Published on by Neuroscientists

Dr. Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai, Wake Forest School of Medicine, United States.

Dr. Kiran K. Solingapuram Sai, PhD, is an Associate Professor with tenure in the Department of Radiology at Wake Forest School of Medicine. He holds a Ph.D. in Organic Chemistry from Northern Illinois University and has extensive research experience in radiopharmaceutical chemistry. His postdoctoral training at Washington University’s Mallinckrodt Institute of Radiology focused on radiotracer development.

Profile

Orcid

 

✨ Early Academic Pursuits

Dr. Kiran K. Solingapuram Sai embarked on his academic journey with a strong foundation in chemistry, earning a Bachelor of Science degree in Chemistry, Biochemistry, and Microbiology from Osmania University, Hyderabad, India, in 2001. His passion for organic chemistry led him to pursue a Master of Science in the same field at Osmania University, where he honed his expertise in chemical synthesis and molecular interactions. Determined to explore the depths of organic chemistry, he pursued his Ph.D. at Northern Illinois University, DeKalb, IL, under the mentorship of Dr. Douglas A. Klumpp. During this period, his research focused on synthetic methodologies and organic reaction mechanisms, paving the way for his future contributions to medicinal and radiopharmaceutical chemistry.

🌐 Professional Endeavors

Dr. Sai’s professional journey commenced with a prestigious postdoctoral research associate position at the Mallinckrodt Institute of Radiology at Washington University in St. Louis, MO, where he worked under the guidance of Dr. Robert H. Mach. During his tenure from 2010 to 2013, he delved into the complexities of radiochemistry, developing novel radiotracers and exploring their applications in medical imaging. This experience laid the groundwork for his career in radiopharmaceutical sciences. In 2014, he joined Wake Forest School of Medicine as a Research Instructor and Chief Radiochemist, marking the beginning of his significant contributions to translational imaging and radiopharmaceutical production.

⚛️ Contributions and Research Focus

At Wake Forest School of Medicine, Dr. Sai played a pivotal role in the Department of Radiology and the Clinical Translational Science Institute (CTSI). He specialized in managing clinical and research-based radiopharmaceutical production at the Wake Forest PET Research Center. As a cyclotron manager and coordinator, he oversaw the synthesis and quality control of radiotracers essential for PET imaging. His expertise extended to the development and implementation of cGMP-approved protocols for C-11 and F-18 radiopharmaceutical production, ensuring the highest standards of safety and efficacy. His research focuses on advancing PET imaging techniques, exploring new radiotracers for diagnostic and therapeutic applications, and improving imaging biomarker development.

🏆 Accolades and Recognition

Dr. Sai’s dedication to radiochemistry and molecular imaging has earned him recognition in the scientific community. His work has been instrumental in developing radiopharmaceuticals for neurological and oncological imaging, contributing significantly to early disease detection and targeted therapy. His contributions have been acknowledged through numerous research grants, collaborative projects, and publications in high-impact scientific journals. His commitment to excellence and innovation has positioned him as a leading figure in the field of radiopharmaceutical sciences.

🔬 Impact and Influence

Beyond his research and technical expertise, Dr. Sai has mentored budding scientists and researchers in the field of radiochemistry and imaging sciences. His guidance has helped shape the next generation of radiopharmaceutical experts, fostering a culture of innovation and scientific curiosity. His role in translational imaging programs has bridged the gap between basic research and clinical applications, directly impacting patient care by improving diagnostic imaging techniques.

💡 Legacy and Future Contributions

Dr. Sai’s work continues to inspire advancements in molecular imaging and radiopharmaceutical development. As an Associate Professor with tenure at Wake Forest School of Medicine, he remains dedicated to pushing the boundaries of radiochemistry, developing cutting-edge imaging agents, and enhancing the precision of diagnostic medicine. His legacy in the field is defined by his unwavering commitment to scientific discovery, translational research, and the continuous pursuit of excellence in radiopharmaceutical sciences.Dr. Kiran K. Solingapuram Sai’s contributions to the field of radiopharmaceutical chemistry stand as a testament to his dedication, innovation, and impact on medical imaging and healthcare. His journey from a passionate chemistry student to a distinguished professor and researcher highlights the transformative power of science in shaping the future of medicine.

 

Publication

  1. Radiation-induced brain injury in non-human primates: A dual tracer PET study with [11C]MPC-6827 and [11C]PiB

    • Authors: Naresh Damuka, George W. Schaaf, Mack Miller, Caleb Bradley, Bhuvanachandra Bhoopal, Ivan Krizan, Krishna K. Gollapelli, Christopher T. Whitlow, J. Mark Cline, Kiran K. Solingapuram Sai
    • Year: 2025

 

  1. The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

    • Authors: Hilal A. Rather, Sameh Almousa, Ashish Kumar, Mitu Sharma, Isabel Pennington, Susy Kim, Yixin Su, Yangen He, Abdollah R. Ghara, Kiran Kumar Solingapuram Sai et al.
    • Year: 2023

 

  1. Development and Optimization of 11C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process

    • Authors: Paul Josef Myburgh, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents

    • Authors: Avinash H. Bansode, Bhuvanachandra Bhoopal, Krishna Kumar Gollapelli, Naresh Damuka, Ivan Krizan, Mack Miller, Suzanne Craft, Akiva Mintz, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains

    • Authors: Naresh Damuka, Paul W. Czoty, Ashley T. Davis, Michael Nader, Susan H. Nader, Suzanne Craft, Shannon L. Macauley, Lindsey K. Galbo Thomma, Phillip M. Epperly, Christopher T. Whitlow et al.
    • Year: 2020

 

  1. One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists

    • Authors: Nagaraju Bashetti, J.V. Shanmukha Kumar, Naresh Varma Seelam, B. Prasanna, Akiva Mintz, Naresh Damuka, Sriram Devanathan, Kiran Kumar Solingapuram Sai
    • Year: 2019

 

Conclusion

Dr. Kiran K. Solingapuram Sai has established himself as a leading expert in radiopharmaceutical sciences, contributing significantly to translational imaging research. His work in PET radiopharmaceutical production and quality assurance underscores his role in advancing medical imaging techniques. His academic and research contributions make him a valuable asset in the field of radiology and molecular imaging.

Alessandro Bortolotti | Psychology | Best Researcher Award

Published on by Neuroscientists

Dr. Alessandro Bortolotti | Psychology | Best Researcher Award

Dr. Alessandro Bortolotti,  University G. d’Annunzio Chieti-Pescara, Italy.

Dr. Alessandro Bortolotti is an expert in business, behavioral sciences, and cognitive psychology, with a strong academic background in neuroscience and decision-making. He earned his Ph.D. from Università degli Studi G. d’Annunzio Chieti e Pescara, focusing on neuromarketing and unconscious choices in the wine market, particularly the influence of color. His educational journey includes advanced studies in business administration, innovation management, and psychology. His research expertise spans cognitive neuroscience, neuropsychology, language development, and decision-making, integrating psychology with business analytics. He is also a licensed psychologist in the Campania region and actively contributes to academic and professional research platforms.

Profile

Google Scholar

✨ Early Academic Pursuits

Born on January 12, 1993, in Italy, Alessandro Bortolotti developed a keen interest in psychology and cognitive sciences from an early age. His academic journey began at the University Gabriele D’Annunzio Chieti-Pescara, where he earned a degree in Psychological Sciences and Techniques in 2015. His early research focused on cognitive psychology, biogenetic foundations, and psychometric techniques. His undergraduate thesis, titled Mozart Effect, explored the impact of music on cognitive function, reflecting his initial foray into experimental psychology under the guidance of Prof. Beth Fairfield. This foundational phase laid the groundwork for his specialization in cognitive and decision-making processes.

🎓 Professional Endeavors

With a passion for understanding human behavior and decision-making, Bortolotti pursued a Master’s degree in Cognitive Psychology from the same university, completing it in 2018. His thesis, When the Valence is Coloured: The Binding Effect in Short-Term Memory, highlighted the interplay between color perception and cognitive processing. Under the mentorship of Prof. Beth Fairfield and Prof. Nicola Mammarella, he delved deeper into cognitive neuroscience, neuropsychology, and psychology of perception. His growing expertise in experimental psychology and neuromarketing led him to pursue a Ph.D. in Business and Behavioural Sciences at Università degli Studi G. d’Annunzio Chieti e Pescara. Between 2019 and 2023, his doctoral research, Neuromarketing and Unconscious Choices in the Wine Market: The Role of Color, explored how sensory stimuli influence consumer behavior, blending psychology with market dynamics.

🔬 Contributions and Research Focus

Dr. Bortolotti’s research is anchored in cognitive neuroscience, neuromarketing, and decision-making. His interdisciplinary work investigates the psychological underpinnings of consumer behavior, particularly the effects of color and perception on purchasing decisions. He has explored key topics such as attentional bias, temporal discounting, and neurophysiological mechanisms in consumer choices. His scholarly contributions include research on color psychology in marketing, the neurocognitive impact of brand perception, and the intersection of psychology and economics in decision-making. His studies, published in reputable journals, provide valuable insights into how unconscious cognitive processes drive consumer engagement and brand preference.

🌟 Accolades and Recognition

Dr. Bortolotti’s expertise has earned him recognition in both academic and professional circles. He holds an Italian Professional Psychologist License (N° 9139 – Regione Campania), enabling him to bridge theoretical research with practical applications in psychology and marketing. His academic excellence is reflected in his multiple publications, which contribute to the evolving field of neuromarketing. His participation in international conferences and research collaborations has established him as a prominent voice in cognitive psychology and behavioral science.

💡 Impact and Influence

Through his research, Dr. Bortolotti has significantly influenced the fields of neuromarketing and consumer psychology. His insights into the unconscious drivers of decision-making have practical applications in advertising, brand positioning, and business analytics. His work has been instrumental in shaping marketing strategies that leverage neuroscience principles to optimize consumer engagement. His research on vaccine hesitancy, attentional biases, and the psychological effects of color extends beyond marketing, offering critical insights into behavioral responses in various social contexts.

🎨 Legacy and Future Contributions

As an academic and researcher, Dr. Bortolotti continues to push the boundaries of neuromarketing, cognitive psychology, and decision sciences. His commitment to exploring the neurological and psychological mechanisms underlying human behavior paves the way for innovative applications in business, healthcare, and digital marketing. His future endeavors aim to integrate advanced neuroscience techniques, such as brain imaging and artificial intelligence, into consumer research, further revolutionizing the understanding of human choices.

✨ Connecting the Dots

With a strong academic foundation, pioneering research, and a vision for the future, Dr. Alessandro Bortolotti embodies the synergy between psychology, business, and neuroscience. His journey from cognitive psychology to neuromarketing demonstrates the power of interdisciplinary research in unraveling the complexities of human behavior. As he continues his work, his contributions promise to leave a lasting impact on both scientific inquiry and practical applications in behavioral economics and marketing strategies.

Publication

  • Temporal discounting of money and face masks during the COVID-19 pandemic: the role of hoarding level
    Authors: L. Cannito, S. Anzani, A. Bortolotti, R. Palumbo, I. Ceccato, A. Di Crosta, …
    Year: 2021

 

  • The promise of color in marketing: use, applications, tips and neuromarketing
    Authors: A. Bortolotti, L. Cannito, S. Anzani, R. Palumbo
    Year: 2023

 

  • Do older and younger adults prefer the positive or avoid the negative?
    Authors: B. Fairfield, C. Padulo, A. Bortolotti, B. Perfetti, N. Mammarella, M. Balsamo
    Year: 2022

 

  • Bored with boredom? Trait boredom predicts internet addiction through the mediating role of attentional bias toward social networks
    Authors: L. Cannito, I. Ceccato, E. Annunzi, A. Bortolotti, E. D’Intino, R. Palumbo, …
    Year: 2023

 

  • About the influence of color perceived lightness on psychological functions
    Authors: A. Bortolotti, L. Cannito, S. Anzani, M. Rossi, R. Palumbo
    Year: 2022

 

  • Exploring vaccine hesitancy: the twofold role of critical thinking
    Authors: L. Cannito, I. Ceccato, A. Bortolotti, A. Di Crosta, P. La Malva, R. Palumbo, …
    Year: 2024

 

  • Face mask reduces the effect of proposer’s (un)trustworthiness on intertemporal and risky choices
    Authors: L. Cannito, S. Anzani, A. Bortolotti, A. Di Domenico, R. Palumbo
    Year: 2022

 

  • Neuromarketing and unconscious choices in the wine market: The role of color
    Authors: A. Bortolotti
    Year: 2023

 

  • Do color and light affect physiology and psychology in proportional ways?
    Authors: A. Siniscalco, A. Bortolotti, M. Rossi
    Year: 2022

 

  • Imagination vs. routines: Festive time, weekly time, and the predictive brain
    Authors: A. Bortolotti, A. Conti, A. Romagnoli, P.L. Sacco
    Year: 2024

 

Conclusion

Dr. Bortolotti’s multidisciplinary expertise in cognitive psychology, neuromarketing, and decision-making positions him as a valuable researcher in both academic and applied settings. His ability to merge psychological principles with business strategies and neuroscience enhances his contributions to fields such as behavioral economics, marketing, and organizational psychology. With a strong foundation in research methodology, experimental studies, and business analytics, he continues to advance the understanding of human behavior in economic and marketing contexts, making him a key contributor to both psychology and business sciences.

 

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Ali Mehri | Neuroscience | Neuroscience Research Pioneer Award

Published on by Neuroscientists

Dr. Ali Mehri | Neuroscience | Neuroscience Research Pioneer Award

Dr. Ali Mehri Babol, Noshirvani University of Technology, Iran.

Dr. Ali Mehri is a prominent physicist whose academic journey has bridged the fields of solid-state physics, data science, and complex systems. With a Ph.D. in Solid State Physics from the University of Zanjan, his research explores novel interdisciplinary areas such as text mining, complex networks, and thermal and electronic transport in nanostructures. His work, particularly in the application of physical principles to data mining and linguistic studies, has significantly contributed to both theoretical and applied physics. Additionally, his research on the statistical properties of irrational numbers and the connection between Zipf’s exponent and language distribution has broadened the scope of complex systems analysis.

Profile

Google Scholar

Early Academic Pursuits 🎓

Dr. Ali Mehri began his academic journey in physics with a focus on solid-state physics. He completed his Bachelor’s degree in Solid State Physics at Kharazmi University in Tehran, Iran, in 2002. His passion for condensed matter physics led him to pursue a Master’s degree at the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, where he focused on colloidal monolayers in the presence of periodic light fields. Under the guidance of Professor Mir Faez Miri, he laid the foundation for his future research. In 2008, Dr. Mehri earned his Ph.D. in Solid State Physics from the University of Zanjan, where he studied the role of entropy in text mining under the supervision of Professor Amir Hossein Darooneh. This pivotal research provided him with a unique perspective that blends physics with data science.

Professional Endeavors 💼

After completing his education, Dr. Mehri embarked on a career in academia, where he has established himself as a dedicated educator and researcher. He currently serves as a faculty member at the Department of Physics, Babol Noshirvani University of Technology. His professional journey is marked by his deep involvement in research, teaching, and mentoring students, particularly in the fields of data and text mining, complex networks theory, and nanostructures. Over the years, he has collaborated with various national and international researchers, enhancing the global visibility of his work in these specialized areas of study.

Contributions and Research Focus 🔬

Dr. Mehri’s research interests lie at the intersection of physics and data science. His work on text mining using the Hurst exponent is a significant contribution to the emerging field of applying physical principles to analyze textual data. He has also explored the intriguing topic of irrational numbers by studying statistical distances to determine the order of digits. Furthermore, Dr. Mehri’s research extends to the correlation between Zipf’s exponent and the geographical distribution of human languages, which connects his expertise in complex networks theory with linguistics. His exploration of thermal and electronic transport in nanostructures adds a solid foundation to his contributions in condensed matter physics.

Accolades and Recognition 🏅

Throughout his academic career, Dr. Ali Mehri has received numerous accolades for his research contributions. His work, particularly in data mining and complex networks, has earned him recognition both in Iran and internationally. Dr. Mehri’s research has been cited in various scientific journals, showcasing the relevance and impact of his work in advancing knowledge within his fields. His academic achievements have solidified his reputation as a forward-thinking physicist who bridges the gap between theoretical and applied sciences.

Impact and Influence 🌍

Dr. Mehri’s work has had a profound impact on various scientific communities, particularly in the fields of data mining, complex networks, and nanostructures. By introducing concepts like the Hurst exponent to text mining and exploring the relationships between statistical distances and irrational numbers, his research has influenced not only physics but also the interdisciplinary applications of data science. His contributions to understanding the connection between language distribution and Zipf’s law have opened new avenues for researchers in both physics and linguistics, highlighting the diverse impact of his work across disciplines.

Legacy and Future Contributions 🕰️

As Dr. Mehri continues to push the boundaries of research, his legacy will be defined by his ability to merge complex concepts from physics with innovative methodologies from data science. His future contributions are expected to further enhance the understanding of nanostructures, electronic transport, and complex systems. Moreover, his pioneering work in text mining and the analysis of irrational numbers has the potential to lead to groundbreaking advancements in computational physics and data analytics. As his research evolves, Dr. Mehri’s work will undoubtedly inspire future generations of physicists and data scientists, reinforcing his lasting influence in these fields.

Publication

  • Title: The complex networks approach for authorship attribution of books
    Authors: A Mehri, AH Darooneh, A Shariati
    Year: 2012

 

  • Title: Variation of Zipf’s exponent in one hundred live languages: A study of the Holy Bible translations
    Authors: A Mehri, M Jamaati
    Year: 2017

 

  • Title: A nonextensive modification of the Gutenberg–Richter law: q-stretched exponential form
    Authors: AH Darooneh, A Mehri
    Year: 2010

 

  • Title: Word ranking in a single document by Jensen–Shannon divergence
    Authors: A Mehri, M Jamaati, H Mehri
    Year: 2015

 

  • Title: The role of entropy in word ranking
    Authors: A Mehri, AH Darooneh
    Year: 2011

 

  • Title: Keyword extraction by nonextensivity measure
    Authors: A Mehri, AH Darooneh
    Year: 2011

 

  • Title: Tsallis entropy, escort probability and the incomplete information theory
    Authors: AH Darooneh, G Naeimi, A Mehri, P Sadeghi
    Year: 2010

 

  • Title: Text mining by Tsallis entropy
    Authors: M Jamaati, A Mehri
    Year: 2018

 

  • Title: Power-law regularities in human language
    Authors: A Mehri, SM Lashkari
    Year: 2016

 

  • Title: Non-extensive distribution of human eye photoreceptors
    Authors: A Mehri
    Year: 2017

 

Conclusion

Dr. Mehri’s professional career, marked by teaching and research at Babol Noshirvani University of Technology, has earned him national and international recognition. His research continues to influence fields as diverse as data science, linguistics, and condensed matter physics. Looking ahead, his work promises to advance the understanding of nanostructures and foster the further integration of physics with computational and data sciences. Dr. Mehri’s legacy will likely continue to inspire future generations of scientists, underscoring the importance of interdisciplinary collaboration in driving scientific progress.